Non-muscle myosin II is an independent predictor of overall survival for cystectomy candidates with early-stage bladder cancer

Oncology Reports

Volumn 28, Issue 5, 2012, Pages 1625-1632

  Xiong, Dan ^a   Ye, Yun Lin ^a,b   Chen, Ming Kun ^a   Qin, Zi Ke ^a   Li, Man Zhi ^a   Zhang, Hua ^a   Xu, Li Hua ^a   Xu, Zhen Zhou ^a   Zeng, Mu Sheng ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Bladder cancer; Cystectomy candidate; Non muscle myosin heavy chain IIA; Prognosis

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; MYOSIN IIA;

ADULT; ARTICLE; BLADDER CANCER; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; CYSTECTOMY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MICROARRAY ANALYSIS; MOLECULAR MODEL; NONMUSCLE MYOSIN HEAVY CHAIN IIA GENE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECURRENCE FREE SURVIVAL; TUMOR GENE; UPREGULATION;

CYSTECTOMY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NONMUSCLE MYOSIN TYPE IIA; RNA, MESSENGER; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84866454438     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1965     Document Type: Article

References (25)

1. Jacobs BL, Lee CT and Montie JE: Bladder cancer in 2010: how far have we come? CA Cancer J Clin 60: 244-272, 2010.
2. Gu FL and Liu YL: Changing status of genitourinary cancer in recent 50 years. Chin J Urol 2002: 88-90, 2002.
3. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
4. Montie JE, Clark PE, Eisenberger MA, et al: Bladder cancer. J Natl Compr Canc Netw 7: 8-39, 2009.
5. Wasco MJ, Daignault S, Zhang Y, et al: Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection. Urology 70: 69-74, 2007. (Pubitemid 47081105)
6. Zhang M, Tao R, Zhang C and Shen Z: Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies. Urology 76: 902-907, 2010.
7. Vicente-Manzanares M, Ma X, Adelstein RS and Horwitz AR: Non-muscle myosin II takes centre stage in cell adhesion and migration. Nat Rev Mol Cell Biol 10: 778-790, 2009.
8. Arii J, Goto H, Suenaga T, et al: Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1. Nature 467: 859-862, 2010.
9. Simons M, Wang M, McBride OW, et al: Human nonmuscle myosin heavy chains are encoded by two genes located on different chromosomes. Circ Res 69: 530-539, 1991.
10. Burt RA, Joseph JE, Milliken S, Collinge JE and Kile BT: Description of a novel mutation leading to MYH9-related disease. Thromb Res 122: 861-863, 2008.
11. Conti MA and Adelstein RS: Nonmuscle myosin II moves in new directions. J Cell Sci 121: 11-18, 2008. (Pubitemid 351265698)
12. Maeda J, Hirano T, Ogiwara A, et al: Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of post-operative therapy. Br J Cancer 98: 596-603, 2008.
13. Minamiya Y, Nakagawa T, Saito H, et al: Increased expression of myosin light chain kinase mRNA is related to metastasis in non-small cell lung cancer. Tumour Biol 26: 153-157, 2005.
14. Xia ZK, Yuan YC, Yin N, Yin BL, Tan ZP and Hu YR: Nonmuscle myosin IIA is associated with poor prognosis of esophageal squamous cancer. Dis Esophagus: Sep 23, 2011 (Epub ahead of print). doi: 10.1111/j.1442-2050.2011.01261.x.
15. Richards KL, Zhang B, Sun M, et al: Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early-stage nonsmall cell lung cancers. Cancer 117: 606-617, 2011.
16. Dyrskjøt L, Kruhøffer M, Thykjaer T, et al: Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res 64: 4040-4048, 2004. (Pubitemid 38697320)
17. Sanchez-Carbayo M, Socci ND, Lozano J, Saint F and Cordon-Cardo C: Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol 24: 778-789, 2006. (Pubitemid 46622045)
18. Botteman MF, Pashos CL, Redaelli A, Laskin B and Hauser R: The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 21: 1315-1330, 2003. (Pubitemid 38041357)
19. Chen W, Luo JH, Hua WF, et al: Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy. Cancer Epidemiol Biomarkers Prev 18: 400-408, 2009.
20. Schrier BP, Hollander MP, van Rhijn BW, Kiemeney LA and Witjes JA: Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Eur Urol 45: 292-296, 2004. (Pubitemid 38221401)
21. Ridley AJ, Schwartz MA, Burridge K, et al: Cell migration: integrating signals from front to back. Science 302: 1704-1709, 2003. (Pubitemid 37505725)
22. Dulyaninova NG, House RP, Betapudi V and Bresnick AR: Myosin-IIA heavy-chain phosphorylation regulates the motility of MDA-MB-231 carcinoma cells. Mol Biol Cell 18: 3144-3155, 2007. (Pubitemid 47235318)
23. Medjkane S, Perez-Sanchez C, Gaggioli C, Sahai E and Treisman R: Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis. Nat Cell Biol 11: 257-268, 2009.
24. Liang S, He L, Zhao X, et al: MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer. PLoS One 6: e18409, 2011.
25. Derycke L, Stove C, Vercoutter-Edouart AS, et al: The role of non-muscle myosin IIA in aggregation and invasion of human MCF-7 breast cancer cells. Int J Dev Biol 55: 835-840, 2011.